The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Alpha FX restarts relationship; Atalaya resources up

Tue, 05th Apr 2022 21:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Alpha FX Group PLC - London-based foreign exchange risk management and international payments - Restarts trading relationship with unnamed "key" Norwegian client. Entered settlement agreement with client in March 2020 at onset of Covid pandemic, where the client was required to make weekly repayments until June 2022 in respect of their obligations for unpaid margins. "Since this date, the client's financial standing has continued to strengthen, and they have consistently met all 104 of their weekly repayment obligations on time. As a result, the gross balance outstanding as at April 1, 2022 has been reduced to GBP2.9 million," company says. Notes it will allow clients to pay outstanding amount over rest of 2022, extending deadline past June 2022.

----------

Marlowe PLC - London-based company focused on business safety and regulatory compliance - Says at Capital Markets Day its trading has been "strong" and expects to meet 2024 strategic and financial targets "materially ahead of schedule". Company says the "significant development" in building its compliance platform - which now encompasses intelligence, consultancy, software and assurance - the reason behind strong trading.

----------

Aferian PLC - Leeds-based video streaming - Acquires 100% share capital of Exabre Ltd, trading as The Filter, a UK-headquartered AI-powered video recommendation service. Initial consideration of deal will GBP1.5 million in cash, with up to GBP2.5 million subject to achieving certain annual recurring revenue growth at increments of additional ARR of GBP500,000. Company says: "The Filter's technology will significantly accelerate the roadmap of 24i's video streaming platform by adding enhanced analytics, recommendations and personalisation to its existing data analytics services. 24i will also market The Filter's managed service solution to its existing OTT and Pay TV customers and prospects as a standalone service."

----------

Glantus Holdings PLC - Dublin-based accounts payable automation and analytics - Agrees new partnership with TealBook, a supplier data firm that powers e-procurement technology. "This partnership will enable customers of both parties to access robust supplier information and insights and stronger AP intelligence," company explains. Adds: "The referral party vendor and supplier information through TealBook's comprehensive supplier intelligence capabilities will enable TealBook customers to utilize the Glantus data analytics solution to understand opportunities for efficiency and risk mitigation within their AP operations and payments."

----------

Redx Pharma PLC - Cheshire-based cancer and fibrosis drug developer - Agrees collaboration with the Garvan Institute of Medical Research, an Australian medical research institute, which expands on company's preclinical work already underway. "The collaboration aims to better understand treatments that could lead to increased patient survival in currently very poorly treated highly fibrotic cancers, such as pancreatic cancer," company says. Adds: "Through this collaboration, Redx and the Garvan will develop an enhanced understanding of cancer-associated fibrosis through detailed scientific studies utilising patient-derived tumour tissue grown in mice, which is thereby able to mimic human disease as closely as possible."

----------

e-Therapeutics PLC - Oxford, England-based computational drug discovery - Enters research collaboration agreement with iTeos Therapeutics Inc, a clinical-stage biopharmaceutical company focused on discovery and development of a new generation of immuno-oncology therapeutics. "The collaboration will focus on the discovery of novel therapeutic approaches and targets in immuno-oncology. e-therapeutics will remain free to explore additional collaborations in the space," company explains. e-therapeutics will receive upfront and near-term cash payments material to the revenue of the company.

----------

Atalaya Mining PLC - copper miner in Spain - Sees "significant" increase in mineral resources at Proyecto Masa Valverde. PMV is located in the Iberian Pyrite Belt of southern Spain. PMV consists of two deposits, Masa Valverde and Majadales. Sees increase in tonnage and contained copper, silver and gold from prior estimate of 42%, 33%, 26% and 34%, respectively. Masa Valverde initial indicated mineral resource now 16.9 million tonnes at 0.66% copper, 1.55% zinc, 0.65% lead, and 27 grammes per tonne silver and 0.55 grammes per tonne gold. Chief Executive Alberto Lavandeira says: "We remain excited about the continued exploration potential at PMV, given the many anomalies our exploration team has identified. We hope to make further discoveries, building on our success in discovering the Majadales deposit, which is shallower and higher grade than Masa Valverde and thus may play a key role in optimising future development scenarios."

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
19 Apr 2024 16:02

IN BRIEF: Redx Pharma shareholders approve AIM delisting plans

Redx Pharma PLC - clinical-stage biotechnology company - Shareholders pass resolution by 99.75% margin at general meeting to approve cancelling shares on AIM in London. This is now expected to take place on May 1, with last day of trading on April 30. Says it remains the company's intention to provide a matched bargain facility to assist shareholders wishing to trade in shares following the AIM delisting. Says it will make further details available in "due course" on its website.

Read more
12 Apr 2024 15:35

Director dealings: Redx Pharma CEO ups stake

(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Read more
2 Apr 2024 16:57

LONDON MARKET CLOSE: Europe down after Easter holiday weekend

(Alliance News) - The FTSE 100 took a hit on Tuesday, after a boost from London's miners and oil firms were not enough to lift the index.

Read more
2 Apr 2024 12:15

Redx Pharma plummets on plans to delist from AIM

(Alliance News) - Redx Pharma PLC shares fell on Tuesday, after it said it intends to cancel its shares from trading on AIM in London.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:50

AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
14 Feb 2024 09:34

IN BRIEF: Redx Pharma clarifies not currently pursuing US listing

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Responds to a Times article published on Tuesday saying RedX is looking to list its shares in New York. Redx says it "wishes to clarify that it is not currently in any process relating to a listing in the US, nor any other jurisdiction".

Read more
7 Feb 2024 11:08

Redx Pharma shares skyrocket on deal to sell inhibitor program

(Alliance News) - Redx Pharma PLC on Wednesday said it has struck a deal to sell Kirsten rat sarcoma virus inhibitor program to Dublin-based Jazz Pharmaceuticals PLC.

Read more
7 Feb 2024 09:29

AIM WINNERS & LOSERS: Verditek falls on cash shell plans

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Oct 2023 12:30

Redx Pharma looks to progress portfolio after raising GBP14.1 million

(Alliance News) - Redx Pharma PLC on Wednesday said that it has conditionally raised around GBP14.1 million by way of a subscription for 54.1 million shares at 26 pence each.

Read more
21 Aug 2023 10:29

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Aug 2023 09:33

Redx Pharma says RXC007 receives orphan drug designation from US FDA

(Alliance News) - Redx Pharma PLC on Monday said its RXC007 drug has received orphan drug designation from the US Food & Drug Administration for the treatment of idiopathic pulmonary fibrosis, a condition causing breathing difficulty due to lung scarring.

Read more
21 Aug 2023 07:43

LONDON BRIEFING: Crest Nicholson lowers annual profit forecast

(Alliance News) - Stocks in London are called flat on Monday, with little in the way of economic data or company updates to reignite risk appetite.

Read more
10 Jul 2023 11:22

Redx Pharma extends term of outstanding notes with two lenders to 2024

(Alliance News) - Redx Pharma PLC on Monday said it extended the term of its outstanding convertible loan notes issued to two lenders RM Special Holdings 3 LLC, otherwise known as Redmile, and Sofinnova Crossover I SLP by a year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.